Division of Infectious Diseases

Welcoming our New Infectious Diseases PGY-2 Pharmacy Resident

We are excited to welcome Molly Miller PharmD as a new PGY-2 in our ID Pharmacy Residency Program! She’s the second ID Pharmacy resident we have had and a fantastic addition to our team! Read on to learn a little more about her…

Ongoing Debate on the Treatment of Staphylococcus aureus Bacteremia

Dr. Andre Kalil, our Director of Transplant Infectious Diseases, recently co-authored a reply to Geriak et al.: “Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.” Debate around the findings of this article was recently featured by Dr. Razan El Ramahi in the IDSA ID journal club and on this blog. In their reply to… Continue Reading

#PharmToExamTable: What is the evidence for continuous infusion dosing of cefazolin?

The following is a clinical review written by Corey Paz, PharmD. Recent graduate of UNMC College of Pharmacy and new PGY1 Pharmacy Resident at Gunderson Health System in LaCrosse, Wisconsin. Follow him on Twitter @coreypaz. Corey was supervised by Scott Bergman, PharmD, FCCP, FIDSA, BCPS. Pharmacy Coordinator for Antimicrobial Stewardship at Nebraska Medicine and Clinical Associate Professor in the UNMC Dept of Pharmacy Practice and… Continue Reading

At the center of the 2018 West Nile Virus season, UNMC ID physicians encountered an unusual presentation

In 2018, we experienced a particularly severe West Nile Virus season, with an unusually high amount of neuroinvasive disease. Last summer, our senior ID Fellow Dr. Lindsey Rearigh shared an informational blog post about the disease, and more recently, she and Dr. Sara Bares published a case report in the Journal of Neurovirology describing a a patient with an unusual presentation of West Nile Virus… Continue Reading

Contraception and Antiretroviral Therapy: Important Interactions to Keep in Mind

Dr. Kimberly Scarsi recently published an important study in Lancet HIV: “Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study.”  We were excited to learn more about and feature her work! Could you please give us a brief summary of the study you performed? This was a pharmacokinetic evaluation of the effect of antiretroviral therapy (ART) on vaginally administered hormones. Overall, 84 women… Continue Reading

About our First Year Fellows – Dr. Clayton Mowrer

Tell us about the position you are starting: I am a quarter of the way through my first two years of a four year adventure as an Internal Medicine/Pediatrics Infectious Diseases fellow here at UNMC. I will spend these first two years here learning adult ID, followed by two years at Children’s Hospital and Medical Center here in Omaha, where I will learn pediatric ID…. Continue Reading

COVID-19 – What is UNMC ID doing?

Although it has not been officially declared a pandemic by the World Health Organization (WHO), as of this morning, there were 81, 191 confirmed cases of COVID-19 and 2,768 deaths worldwide. To date, 57 of these cases are within US borders, and there are increasing cases throughout the world. UNMC & Nebraska Medicine have had our quarantine and biocontainment units active and caring for patients… Continue Reading

Freedom is in the Air: My Visit to Sudan, a Born-again Country

Here at UNMC ID, we are thrilled to share the global, and personal efforts, of our faculty. Please take a moment to read this excellent piece by Dr. Nada Fadul; Associate Professor, Division of Infectious Diseases, UNMC Sudan felt different this time. It was the middle of December 2019, the first anniversary of the Sudanese Revolution that caught the world’s attention. The country is going… Continue Reading

About our First Year Fellows – Mark Ridder, MD

Tell us about your current position I a first year fellow of infectious disease at University of NE Medical Center. For the next 2 years I’ll be learning all I can from experts in the field for the diagnosis, treatment, and management of a wide variety of infectious diseases ranging from parasites and fungal disease to complicated blood stream infections. I’ll be learning about these… Continue Reading

Should We Add Daptomycin to β-Lactams in the Initial Treatment of Methicillin-susceptible S. aureus Bacteremia?

Content from Dr. Razan El Ramahi, originally posted in IDSA journal club.  Despite the availability of active antibiotics to treat Staphylococcus aureus bacteremia (SAB), controversy still exists regarding the optimal antibiotic strategy and whether combination antibiotics improve outcomes. In small clinical studies, a possible benefit was observed by adding daptomycin to β-lactams in the treatment of SAB. However, the numbers of methicillin-susceptible S. aureus (MSSA) cases in these studies, published… Continue Reading